This study exists to understand how the medication ITI-007 holds up over time after the earliest research stage. Researchers are trying to understand how people respond to the medication ITI-007 in practice and what may need to be adjusted.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: Intra-Cellular Therapies, Inc.
Condition: Bipolarity, Depression

View study

CompletedNCT02600507

Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Depression for depression in bipolarity

This study is completed in the United States, in Bulgaria, in Russia, .... It is testing Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Depression for depression in bipolarity.

In United States

Bipolarity, DepressionDrugFrom 18 Years to 75 Years

Countries: United States, Bulgaria, Russia, ...
Sponsor: Intra-Cellular Therapies, Inc.
Condition: Bipolarity, Depression

View study

CompletedNCT04285515

study Evaluating Lumateperone Monotherapy in the Treatment of Depression in bipolarity or Major Depressive Disorder

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand whether a therapy or guided support program can give earlier or clearer feedback during care.

In United States

Depression, BipolarityDrugFrom 18 Years to 75 Years

Countries: United States, Bulgaria, Russia, ...
Sponsor: Intra-Cellular Therapies, Inc.
Condition: Depression, Bipolarity

View study

TerminatedNCT03593213

Study Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in people with Schizophrenia

This study was terminated in the United States, in Bulgaria, in Malaysia, .... It focuses on schizophrenia.

In United States

SchizophreniaDrugFrom 18 Years to 64 Years

Countries: United States, Bulgaria, Malaysia, ...
Sponsor: AbbVie
Condition: Schizophrenia

View study

CompletedNCT02966873

study for Addiction and PTSD (PTSD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSD, AddictionDrugFrom 18 Years to 70 Years

Countries: United States
Sponsor: Medical University of South Carolina
Condition: PTSD, Addiction

View study

CompletedNCT04471207

study Intelligent Biometrics for PTSD - study

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDBehavioralFrom 18 Years to 75 Years

Countries: United States
Sponsor: Medical University of South Carolina
Condition: PTSD

View study

TerminatedNCT00109577

study of a Nutritional Supplement in Adults With Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugOver 18 Years

Countries: United States, Canada
Sponsor: University of Calgary
Condition: Bipolarity

View study

WithdrawnNCT05440721

study of an Innovative Digital Therapeutic for Smoking Cessation With Biochemical Verification

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: Click Therapeutics, Inc.
Condition: Addiction

View study

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.